Mark Docherty, BEng ACA, Director of Finvector Vision Therapies Limited. He was a founding director of specialist life sciences venture capital company, Merlin Biosciences Limited (now Excalibur Fund Managers Limited) and was actively involved in the structuring and financing of the Merlin start-ups and investments. Previously, he was a Manager in the Corporate Finance Group of Arthur Andersen. He is a chartered accountant and holds a BEng in Mechanical Engineering from Sheffield University. He is a Geschäftsführer of DHP Private Equity GmbH, a specialist private equity house. He is also a non-executive director of ReNeuron Group plc.